Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

a16z Capital Management, L.L.C. 13F Holdings -- Portfolio & Top Positions (2026-06-30)

a16z Capital Management, L.L.C. (CIK 1540358) reported $14.21B across 19 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SPCX ($12.79B, 89.97%), NAVN ($645.4M, 4.54%), RVMD ($172.5M, 1.21%), META ($119.7M, 0.84%), FIG ($108.2M, 0.76%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1SPCXSPACE EXPLORATION TECHN CORP$12.79B89.97%74.9MNew
2NAVNNAVAN INC$645.4M4.54%28.2MHold
3RVMDREVOLUTION MEDICINES INC$172.5M1.21%921,099Hold
4METAMETA PLATFORMS INC$119.7M0.84%212,531Hold
5FIGFIGMA INC$108.2M0.76%6.0MTrimmed
6BIOABIOAGE LABS INC$79.2M0.56%3.2MHold
7XYZBLOCK INC$77.3M0.54%1.0MHold
8ERASERASCA INC$52.4M0.37%2.9MHold
9MAZEMAZE THERAPEUTICS INC$50.8M0.36%1.7MHold
10DMRADAMORA THERAPEUTICS INC$32.2M0.23%1.2MHold
11OMDAOMADA HEALTH INC$25.3M0.18%1.2MTrimmed
12NAUTNAUTILUS BIOTECHNOLOGY INC$16.9M0.12%9.1MTrimmed
13RBLXROBLOX CORP$14.9M0.11%274,570New
14AKTSAKTIS ONCOLOGY INC$13.4M0.09%415,000Hold
15CAMPCAMP4 THERAPEUTICS CORP$9.3M0.07%2.1MHold
16BTGOBITGO HOLDINGS INC$3.5M0.02%666,356Hold
17KLRAKAILERA THERAPEUTICS INC$3.1M0.02%140,000New
18DNAGINKGO BIOWORKS HOLDINGS INC$1.1M0.01%108,568Hold
19IPSTIP STRATEGY HOLDINGS INC$00.00%0Exited
20IPSTIP STRATEGY HOLDINGS INC$9,7220.00%4,137New

Source: SEC Form 13F filings · as of 2026-06-30